Oncology & Cancer

Statin use linked to lower prostate cancer death risk

(HealthDay)—Prostate cancer patients who take the cholesterol-lowering drugs known as statins appear to face a lower risk of death from their disease, new Canadian research suggests.

Oncology & Cancer

Weight at time of diagnosis linked to prostate cancer mortality

Men who are overweight or obese when they are diagnosed with prostate cancer are more likely to die from the disease than men who are of healthy weight, according to a Kaiser Permanente study published today in the journal ...

Oncology & Cancer

Cumulative metformin linked to mortality post-prostate cancer

(HealthDay)—Among elderly men with diabetes, increased cumulative duration of metformin following a prostate cancer (PC) diagnosis correlates with decreased all-cause and PC-specific mortality, according to a study published ...

Oncology & Cancer

Prostate cancer decision making: How race factors in

(Medical Xpress)—What factors influence a man when he is choosing treatment for prostate cancer? Race and evolving treatment recommendations for prostate cancer both play roles.

Oncology & Cancer

Digital rectal exam remains important part of prostate screening

(Medical Xpress)—The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to ...

page 6 from 8